Copy to clipboard 
VISIE (formerly Advanced Scanners) joined NVIDIA Inception, a program that empowers early-stage companies that seek to revolutionize industries with technological advancements.
VISIE is a medtech growth company researching, developing and commercializing deep-tech optical scanners that are intended for use in robotic and navigated orthopedic, neuro and spine surgery. VISIE’s optical scanners can produce snap image registration with over 1 million data points in just a second. They are designed to simplify surgical workflows and shave significant time off surgery while simultaneously increasing surgical precision by a factor greater than 10.
VISIE plans to leverage resources available through NVIDIA Inception, including NVIDIA’s powerful video-streaming tools, large language models (LLMs), machine learning (ML) pipelines, hardware and software development kits (SDKs), as well as access to technical training and next-generation architectural design advice.
Tony Wonsyld, VISIE’s Director of Software Engineering, reports, “We will use NVIDIA’s resources to optimize our proprietary hardware and algorithms to make real-time patient tracking a reality. Further, the resources provided through NVIDIA Inception will support our efforts to provide a discrete hardware solution that easily integrates with surgical robotic and navigation systems to fulfill our customer needs.”
The program will also offer VISIE’s scientists and engineers the opportunity to collaborate with experts to further its AI-driven offerings.
“My team is eager to get their hands on NVIDIA’s resources. There is a tremendous amount for us to explore and leverage within Inception,” says Michael Landry, VISIE’s Head of Engineering. “We fully anticipate adding layers of robustness and efficiencies to our hardware and software with the access to tools we gain through this program.”
Source: VISIE Inc.
VISIE (formerly Advanced Scanners) joined NVIDIA Inception, a program that empowers early-stage companies that seek to revolutionize industries with technological advancements.
VISIE is a medtech growth company researching, developing and commercializing deep-tech optical scanners that are intended for use in robotic and navigated orthopedic,...
VISIE (formerly Advanced Scanners) joined NVIDIA Inception, a program that empowers early-stage companies that seek to revolutionize industries with technological advancements.
VISIE is a medtech growth company researching, developing and commercializing deep-tech optical scanners that are intended for use in robotic and navigated orthopedic, neuro and spine surgery. VISIE’s optical scanners can produce snap image registration with over 1 million data points in just a second. They are designed to simplify surgical workflows and shave significant time off surgery while simultaneously increasing surgical precision by a factor greater than 10.
VISIE plans to leverage resources available through NVIDIA Inception, including NVIDIA’s powerful video-streaming tools, large language models (LLMs), machine learning (ML) pipelines, hardware and software development kits (SDKs), as well as access to technical training and next-generation architectural design advice.
Tony Wonsyld, VISIE’s Director of Software Engineering, reports, “We will use NVIDIA’s resources to optimize our proprietary hardware and algorithms to make real-time patient tracking a reality. Further, the resources provided through NVIDIA Inception will support our efforts to provide a discrete hardware solution that easily integrates with surgical robotic and navigation systems to fulfill our customer needs.”
The program will also offer VISIE’s scientists and engineers the opportunity to collaborate with experts to further its AI-driven offerings.
“My team is eager to get their hands on NVIDIA’s resources. There is a tremendous amount for us to explore and leverage within Inception,” says Michael Landry, VISIE’s Head of Engineering. “We fully anticipate adding layers of robustness and efficiencies to our hardware and software with the access to tools we gain through this program.”
Source: VISIE Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
